Paper21079150
Constitutive reductions in mTOR alter cell size, immune cell development, and antibody production.
Zhang S and 13 others. Blood, 2011. Cited by 112 papers, by iCite.
Cite this record
ConductScience Library. Constitutive reductions in mTOR alter cell size, immune cell development, and antibody production. Papers, record 21079150. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21079150
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Constitutive reductions in mTOR alter cell size, immune cell development, and antibody production.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibody Formation | Major topic |
| B-Lymphocytes | Major topic |
| TOR Serine-Threonine Kinases | Major topic |
| Animals | |
| Body Size | |
| Cell Differentiation | |
| Cell Lineage | |
| Cell Size | |
| Down-Regulation | |
| Gene Knockdown Techniques | |
| Mice | |
| Mice, Inbred BALB C | |
| Mice, Transgenic | |
| Organ Size | |
| Spleen |
Source PubMed
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| Intramural NIH HHS | United States | PubMed | PubMed | ||
| ZIABC010008 | NIH | NIH RePORTER | |||
| ZIABC011065 | NIH | NIH RePORTER | |||
| ZIAHG000123 | NIH | NIH RePORTER | |||
| ZICBC011047 | NIH | NIH RePORTER | |||
| ZICBC011265 | NIH | NIH RePORTER |
References50
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16962653 | SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. | Cell | 2006 | https://conductscience.org/library/papers/16962653 | PubMed |
| 2 | 19209957 | Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2. | PLoS Biol | 2009 | https://conductscience.org/library/papers/19209957 | PubMed |
| 3 | 7692641 | Responsiveness of preactivated B cells to IL-2 and IL-6. Effect of cyclosporine and rapamycin. | Transplantation | 1993 | https://conductscience.org/library/papers/7692641 | PubMed |
| 4 | 19390566 | Immunoregulatory functions of mTOR inhibition. | Nat Rev Immunol | 2009 | https://conductscience.org/library/papers/19390566 | PubMed |
| 5 | 17680028 | Expanding mTOR signaling. | Cell Res | 2007 | https://conductscience.org/library/papers/17680028 | PubMed |
| 6 | 19538929 | The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. | Immunity | 2009 | https://conductscience.org/library/papers/19538929 | PubMed |
| 7 | 14634209 | Frap, FKBP12 rapamycin-associated protein, is a candidate gene for the plasmacytoma resistance locus Pctr2 and can act as a tumor suppressor gene. | Proc Natl Acad Sci U S A | 2003 | https://conductscience.org/library/papers/14634209 | PubMed |
| 8 | 10079223 | The flat-top gene is required for the expansion and regionalization of the telencephalic primordium. | Development | 1999 | https://conductscience.org/library/papers/10079223 | PubMed |
| 9 | 15485918 | Disruption of the mouse mTOR gene leads to early postimplantation lethality and prohibits embryonic stem cell development. | Mol Cell Biol | 2004 | https://conductscience.org/library/papers/15485918 | PubMed |
| 10 | 15268862 | Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. | Curr Biol | 2004 | https://conductscience.org/library/papers/15268862 | PubMed |
| 11 | 18424697 | Cutting edge: Foxp3-mediated induction of pim 2 allows human T regulatory cells to preferentially expand in rapamycin. | J Immunol | 2008 | https://conductscience.org/library/papers/18424697 | PubMed |
| 12 | 14673156 | mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E. | Mol Cell Biol | 2004 | https://conductscience.org/library/papers/14673156 | PubMed |
| 13 | 11236653 | Isolation, microinjection, and transfer of mouse blastocysts. | Methods Mol Biol | 2001 | https://conductscience.org/library/papers/11236653 | PubMed |
| 14 | 15533996 | Balancing Akt with S6K: implications for both metabolic diseases and tumorigenesis. | J Cell Biol | 2004 | https://conductscience.org/library/papers/15533996 | PubMed |
| 15 | 18037889 | Follicular shuttling of marginal zone B cells facilitates antigen transport. | Nat Immunol | 2008 | https://conductscience.org/library/papers/18037889 | PubMed |
| 16 | 17996694 | Rapamycin inhibits differentiation of Th17 cells and promotes generation of FoxP3+ T regulatory cells. | Int Immunopharmacol | 2007 | https://conductscience.org/library/papers/17996694 | PubMed |
| 17 | 12466966 | Tuberin, the tuberous sclerosis complex 2 tumor suppressor gene product, regulates Rho activation, cell adhesion and migration. | Oncogene | 2002 | https://conductscience.org/library/papers/12466966 | PubMed |
| 18 | 20072130 | Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitor. | Nat Med | 2010 | https://conductscience.org/library/papers/20072130 | PubMed |
| 19 | 11069885 | Genetic and biochemical characterization of dTOR, the Drosophila homolog of the target of rapamycin. | Genes Dev | 2000 | https://conductscience.org/library/papers/11069885 | PubMed |
| 20 | 19720745 | Characterization of Rictor phosphorylation sites reveals direct regulation of mTOR complex 2 by S6K1. | Mol Cell Biol | 2009 | https://conductscience.org/library/papers/19720745 | PubMed |
Cited by97
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 112 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42775680 | Therapeutic Immune Reprogramming by Rapamycin Attenuates Plaque Inflammation and Lymphoid Immune Responses in Aged Atherosclerotic Mice. | Aging Cell | 2026 | https://conductscience.org/library/papers/42775680 | PubMed |
| 42695413 | Autophagy determines the fate of immune cells by regulating metabolic remodeling and PANoptosis (Review). | Int J Mol Med | 2026 | https://conductscience.org/library/papers/42695413 | PubMed |
| 41947998 | mTOR Signaling Pathway in Antiphospholipid Syndrome: Pathogenesis and Potential Therapeutic Targets. | Drug Des Devel Ther | 2026 | https://conductscience.org/library/papers/41947998 | PubMed |
| 41929100 | Multiple mTOR RNA localization signals regulate subcellular protein synthesis and axonal growth. | bioRxiv | 2026 | https://conductscience.org/library/papers/41929100 | PubMed |
| 41912890 | A renaissance in targeting the PI3K/AKT/mTOR pathway. | Nat Rev Drug Discov | 2026 | https://conductscience.org/library/papers/41912890 | PubMed |
| 41789635 | mTOR signaling pathway in primary Sjögren's syndrome: Pathogenesis and potential therapeutic targets (Review). | Int J Mol Med | 2026 | https://conductscience.org/library/papers/41789635 | PubMed |
| 41026602 | Biphasic control of the B cell transcriptome by mTORC1 and GSK3. | Cell Rep | 2025 | https://conductscience.org/library/papers/41026602 | PubMed |
| 40649833 | Autophagy Differentially Influences Toll-like Receptor 9 and B Cell-Receptor-Mediated B Cell Expansion, Expression of Major Histocompatibility Class II Proteins, and Antigenic Peptide Presentation. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40649833 | PubMed |
| 40498369 | mTOR Modulates NLRP3 Inflammasome Activation via Nuclear Translocation and STAT1 Inhibition. | Eur J Immunol | 2025 | https://conductscience.org/library/papers/40498369 | PubMed |
| 40450038 | Selection and validation of reference genes for RT-qPCR normalization in dormant cancer cells. | Sci Rep | 2025 | https://conductscience.org/library/papers/40450038 | PubMed |
| 38900644 | Eukaryotic cell size regulation and its implications for cellular function and dysfunction. | Physiol Rev | 2024 | https://conductscience.org/library/papers/38900644 | PubMed |
| 37895302 | Molecular Mechanisms Underpinning Immunometabolic Reprogramming: How the Wind Changes during Cancer Progression. | Genes (Basel) | 2023 | https://conductscience.org/library/papers/37895302 | PubMed |
| 37779156 | Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease. | Signal Transduct Target Ther | 2023 | https://conductscience.org/library/papers/37779156 | PubMed |
| 37724220 | Rapamycin Augmentation of Chronic Ketamine as a Novel Treatment for Complex Regional Pain Syndrome. | Cureus | 2023 | https://conductscience.org/library/papers/37724220 | PubMed |
| 36467738 | HIV-1 replication and latency are balanced by mTOR-driven cell metabolism. | Front Cell Infect Microbiol | 2022 | https://conductscience.org/library/papers/36467738 | PubMed |
| 36061862 | Human endothelial cell-derived exosomal microRNA-99a/b drives a sustained inflammatory response during sepsis by inhibiting mTOR expression. | Front Cell Infect Microbiol | 2022 | https://conductscience.org/library/papers/36061862 | PubMed |
| 35897651 | The mTOR Signaling Pathway in Multiple Sclerosis; from Animal Models to Human Data. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35897651 | PubMed |
| 35857466 | Progerin modulates the IGF-1R/Akt signaling involved in aging. | Sci Adv | 2022 | https://conductscience.org/library/papers/35857466 | PubMed |
| 35757745 | Harnessing the B Cell Response in Kidney Transplantation - Current State and Future Directions. | Front Immunol | 2022 | https://conductscience.org/library/papers/35757745 | PubMed |
| 34964999 | Conditional deletion of mTOR discloses its essential role in early B-cell development. | Mol Carcinog | 2022 | https://conductscience.org/library/papers/34964999 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| MTOR | 2475 | PubTator's text mining | https://conductscience.org/library/genes/2475 | NCBI Gene |
| RORC | 6097 | PubTator's text mining | https://conductscience.org/library/genes/6097 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21079150
GET https://conductscience.org/api/papers/v1/21079150/references?page=2